Product Code: HLC210A
Report Highlights
The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and should reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Report Includes:
- An overview of the global markets for cardiovascular devices
- Analyses of global market trends, with data from 2016, 2017, and projections of CAGRs through 2022
- Discussion of key cardiovascular procedures, disease areas, and end-users
- Information on cardiovascular devices including diagnostics and monitoring, interventional cardiology, cardiac rhythm management, cardiac assist and other vascular surgery devices
- Analysis of market drivers, restraints and opportunities
- Coverage of key mergers and acquisitions, new product launches, agreements, collaborations and partnerships
- Patent analysis of various devices by year and by assignee
- Profiles of major players in the industry
Report Scope
Cardiovascular devices are used to diagnose and treat various heart diseases and related health problems. With the medical needs of patients at an all-time high, any increase in incidences will only lead to a significant growth of cardiovascular market. This report analyzes the market trends of cardiovascular devices, future growth and regional market of the same.
This report covers cardiovascular diseases such as arrhythmia, cardiomyopathy, coronary heart disease, myocardial infarction, congestion heart failure, congenital heart disease, hypertension, heart infections, and valvular diseases. The procedures considered in this report are cardiac resynchronization therapy, heart transplantation, coronary artery bypass surgery, valve replacement, beat heart surgery, transmyocardial revascularization surgery, balloon valvuloplasty, and renal denervation surgery. The end-users covered in this report include home and ambulatory care, hospitals, diagnostic laboratories, and research laboratories. The market has been segmented based on device type and geography. The equipment/products/systems include but are not limited to the segments considered in this report. By type, the market in this report is segmented into diagnostics and monitoring devices, and cardiovascular surgical devices. The diagnostic and monitoring cardiac devices include ECG and echocardiogram devices. The cardiovascular surgical devices considered in this report are interventional cardiology devices like stents, angioplasty balloons, catheters and accessories, guidewires, cannulae, and valves; cardiac rhythm management devices like implantable cardiac defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, pacemakers and leads; cardiac assist devices (CAD) like ventricular assist devices, intra-aortic balloon pump, total artificial heart; and other vascular surgery devices like endovascular grafts, IVC filters and occlusion devices.
The research uncovers many paradigms shifts in the studied market, in terms of regional competitive advantage, competitive landscape among the key players in the cardiovascular devices industry, and market dynamics. A holistic study of the market has been carried out by incorporating various factors right from country-specific demographic conditions and business cycles to market specific microeconomic influences that were needed to analyze the future trends of this market. The report provides a comprehensive review of market drivers, restraints, opportunities, and available patents. Key vendor analysis, new products and developments with financials are also provided to enable easy decision making.
Analyst Credentials
Led by Research Head Karthik Arun, the BCC Research Staff is comprised of expert analysts skilled in conducting primary research, secondary research and data analysis and who have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in microbiology, electrical engineering, business administration and surgery, among others.
Table of Contents
Chapter 1: Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related BCC Research Reports
Chapter 2: Summary and Highlights
Chapter 3: Market and Technology Background
- Disease Area
- Arrhythmia
- Cardiomyopathy
- Coronary Heart Disease
- Myocardial Infarction
- Congestion Heart Failure
- Congenital Heart Disease (CHD)
- Hypertension
- Heart Infections
- Valvular Heart Disease
- Procedures
- Cardiac Resynchronization Therapy (CRT)
- Heart Transplantation
- Coronary Artery Bypass Surgery
- Valve Replacement
- Beating Heart Surgery
- Transmyocardial Revascularization Surgery
- Balloon Valvuloplasty
- Renal Denervation Surgery
- End-users
- Home and ambulatory care
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
Chapter 4: Market Breakdown by Device Type
- Device Types
- Cardiac Diagnostics & Monitoring Devices
- ECG
- Echocardiography (Echo)
- Cardiovascular Surgical Devices
- Interventional Cardiology
- Cardiac Rhythm Management (CRM)
- Cardiac Assist Devices
- Other Vascular Surgery Devices
Chapter 5: Market Breakdown by Region
- Global Cardiovascular Devices Market
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain & Portugal
- Scandinavia
- Benelux
- Asia-Pacific
- China
- India
- Japan
- Australia and New Zealand
- South Korea
- Middle East and Africa
- GCC
- South Africa
- Rest of MEA
- South America
- Brazil
- Argentina
- Rest of South America
Chapter 6: Drivers and Restraints-Global Impact Analysis
- Drivers
- Rising Incidence of Cardiovascular Disorders and Other Lifestyle Related Disorders
- Growing Geriatric Population
- Technological Advancements
- Increasing Demand for Minimally Invasive Surgeries
- Increasing Adoption of Telemedicine, Remote Patient Monitoring and Home Healthcare
- Integration of IT to Increase Market Growth
- Restraints
- Regulatory Constraints
- Reimbursement Issues
- Inflated Cost of Devices
- Slow Adoption of Technologies
- Intense Competition
- Unfavourable Impact of Foreign Currency Exchange
Chapter 7: Analysis of Market Opportunities
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Degree of Competition
- Threat of Substitution
- Threat of New Entrants
- PEST Analysis
- Political
- Economical
- Social
- Technological
Chapter 8: Patent Review/New Developments
- Patent Review by Type
- Cardiac Pacemaker and Pacemaker-Related Patents
- Defibrillators
- Stents
- Catheters
- ECG
- Holter Monitor
- Event Monitor
- Implantable Loop Recorder
- Guidewires
- Cannulae
- Valves
- Occlusion Devices
- Left Atrial Appendage Exclusion Devices
- TAVI Systems
- Electrosurgical Devices
- CPR Devices
- Artificial Hearts
- Endovascular Grafts
- IVC Filters
- Vascular Clamps
Chapter 9: Competitive Landscape
- Major Players and Market Share
- Mergers and Acquisitions
- New Product Launches
- Agreements, Collaborations and Partnerships
Chapter 10: Company Profiles
About BCC Research
- About BCC Research
- BCC Membership
- BCC Custom Research
List of Tables
- Summary Table: Global Market for Cardiovascular Devices, by Device Type, Through 2022 ($ Billions)
- Table 1 Global Cardiovascular Surgical and Interventional Procedures in 2016 (Millions/%)
- Table 2 CRT Treatment Cost in United States, 2016 ($)
- Table 3 Number of Heart Transplants in USA, 2015-2017
- Table 4 Average Heart Transplantation Therapy Cost in United States, 2016 ($)
- Table 5 Cost of CABG Therapy, by Country, 2016 ($)
- Table 6 Treatments and Cost Related to Valve Replacement in India, 2016 ($)
- Table 7 Global Cardiovascular Devices Market, by Device Type, Through 2022 ($ Billions)
- Table 8 Global Cardiac Diagnostic and Monitoring Devices Market, Through 2022 ($ Billions)
- Table 9 Global Cardiac Diagnostic and Monitoring Devices Market Growth, by Region, Through 2022 ($ Billions)
- Table 10 Global Interventional Cardiology Devices Market, Through 2022 ($ Billions)
- Table 11 Global Interventional Cardiology Devices Market, by Region, Through 2022 ($ Billions)
- Table 12 Global Cardiac Rhythm Management Devices Market, by Region, Through 2022 ($ Billions)
- Table 13 Global Cardiac Assist Devices Market, by Region, Through 2022 ($ Billions)
- Table 14 Global Other Vascular Devices Market, by Region, Through 2022 ($ Billions)
- Table 15 Cardiovascular Devices Cleared or Approved by FDA, 2016 and 2017
- Table 16 Global Cardiovascular Devices Market, by Region, Through 2022 ($ Billions)
- Table 17 North America Cardiovascular Devices Market, by Region, Through 2022 ($ Billions)
- Table 18 Leading U.S. Cardiology and Heart Surgery Institutions, 2016-2017
- Table 19 Europe Cardiovascular Devices Market, by Region, Through 2022 ($ Billions)
- Table 20 Some of the Leading U.K. Hospitals Offering Adult Cardiac Surgery
- Table 21 Asia-Pacific Cardiovascular Devices Market, Through 2022 ($ Billions)
- Table 22 Middle East and Africa Cardiovascular Devices Market, by Region, Through 2022 ($ Billions)
- Table 23 South America Cardiovascular Devices Market, by Region, Through 2022 ($ Billions)
- Table 24 Average Estimated Percentage Prevalence of Lifestyle Diseases, 2016 (%)
- Table 25 Advances in Cardiology
- Table 26 Wearable Commercial Products for Monitoring Physiological Signs and Activities
- Table 27 Recent FDA Recalls of Cardiovascular Devices
- Table 28 Cardiac Pacemakers Patents, Through November 2017
- Table 29 Defibrillators Patents, Through November 2017
- Table 30 Stents Patents, Through December 2017
- Table 31 Catheters Patents, Through November 2017
- Table 32 ECG Patents, Through September 2017
- Table 33 Holter Monitor Patents, June-August 2016
- Table 34 Event Monitor Patents, Through April 2017
- Table 35 Impantable Loop Recorder Patents, February 2017
- Table 36 Guidewires Patents, Through November 2017
- Table 37 Cannulae Patents, Through November 2017
- Table 38 Valves Patents, Through November 2017
- Table 39 Occlusion Devices Patents, Through June 2017
- Table 40 LAA Exclusion Devices Patents, November 2016
- Table 41 TAVI Systems Patents, Through August 2017
- Table 42 Electrosurgical Devices Patents, Through October 2017
- Table 43 CPR Devices Patents, Through November 2017
- Table 44 Artificial Hearts Patents, Through September 2017
- Table 45 Endovascular Grafts Patents, Through November 2017
- Table 46 IVC Filters Patents, Through November 2017
- Table 47 Vascular Clamps Patents, Through November 2017
- Table 48 Mergers and Acquisitions, 2016-2017
- Table 49 New Product Launches, 2016-2017
- Table 50 Agreements, Collaborations and Partnerships, 2016-2017
- Table 51 Abbott Vascular Products and Services
- Table 52 Abbott Overall Financials, 2015-2016 ($ Billions)
- Table 53 Abbott Vascular Products: Financials, 2015-2016 ($ Billions)
- Table 54 St. Jude Medical (Acquired by Abbott) Products
- Table 55 St. Jude Medical Financials, 2015-2016 ($ Billions)
- Table 56 Abiomed, Inc. Products and Services
- Table 57 Abiomed, Inc. Financials, 2015-2016 ($ Billions)
- Table 58 Abiomed, Inc. Financials, 2016-2017 ($ Billions)
- Table 59 B. Braun Products and Services
- Table 60 B. Braun Financials, 2015-2016 ($ Billions)
- Table 61 Biotronik Products and Services
- Table 62 BSC Products and Services
- Table 63 BSC Financials, 2015-2016 ($ Billions)
- Table 64 Cardinal Health Vascular Products
- Table 65 Cardinal Health, Inc. Financials, 2015-2016 ($ Billions)
- Table 66 Cardinal Health, Inc. Financials, 2016-2017 ($ Billions)
- Table 67 Cardinal Health, Inc. Revenue by Operations, 2015-2017 ($ Billions)
- Table 68 Cordis Corporation Products and Services
- Table 69 Cook Medical Inc. Products and Services
- Table 70 GE Financials, 2015-2016 ($ Billions)
- Table 71 GR Healthcare Revenue, 2016-2017 ($ Billions)
- Table 72 GE Healthcare Products and Services
- Table 73 J&J Products and Services
- Table 74 J&J Revenue, 2015-2016 ($ Billions)
- Table: 75 Medtronic Products and Services
- Table 76 Medtronic Financials, 2015-2016 ($ Billions)
- Table 77 Medtronic Cardiac and Vascular Group Sales, 2016-2017(Q3) ($ Billions)
- Table 78 Medtronic Minimally Invasive Therapy Group Sales, 2016-2017(Q3) ($ Billions)
- Table 79 Philips Healthcare Products and Services
- Table 80 Philips Revenue, 2015-2016 ($ Billions)
- Table 81 Siemens Healthineers Products and Services
- Table 82 Philips Healthineers Financials, 2015-2016 ($ Billions)
- Table 83 Sorin/Livanova Products and Services
- Table 84 Livanova Financials, 2015-2016 ($ Billions)
- Table 85 Terumo Medical Corporation Products and Services
- Table 86 Terumo Medical Corporation Financials, 2015-2016 ($ Billions)
List of Figures
- Summary Figure: Global Market for Cardiovascular Devices, by Device Type, 2016-2022 ($ Billions)
- Figure 1 Noncommunicable Diseases Mortality Share, by Cause of Death, 2016 (%)
- Figure 2 Global Cardiovascular Devices Market, by Device Type, 2016-2022 ($ Billions)
- Figure 3 Global Cardiac Diagnostic and Monitoring Devices Market, 2016-2022 ($ Billions)
- Figure 4 Global Cardiovascular Electrocardiography Market, 2016-2022 ($ Billions)
- Figure 5 Global Cardiovascular Echocardiography Market, 2016-2022 ($ Billions)
- Figure 6 Global Interventional Cardiology Market, 2016-2022 ($ Billions)
- Figure 7 Global Cardiovascular Stents Market, 2016-2022 ($ Billions)
- Figure 8 Global Cardiovascular Catheters and Accessories Market, 2016-2022 ($ Billions)
- Figure 9 Global Cardiovascular Guidewires Market, 2016-2022 ($ Billions)
- Figure 10 Global Cardiovascular Cannuale Market, 2016-2022 ($ Billions)
- Figure 11 Global Heart Valves Market, 2016-2022 ($ Billions)
- Figure 12 Global Cardiac Rhythm Management Devices Market, 2016-2022 ($ Billions)
- Figure 13 Global Cardiac Rhythm Management Devices Market, 2016-2022 ($ Billions)
- Figure 14 Global Implantable Cardiac Defibrillators Market, 2016-2022 ($ Billions)
- Figure 15 Global Cardiac Resynchronization Devices Market, 2016-2022 ($ Billions)
- Figure 16 Global Cardiac Pacemakers Devices Market, 2016-2022 ($ Billions)
- Figure 17 Global Cardiac Resynchronization Devices Market, 2016-2022 ($ Billions)
- Figure 18 Global Cardiac Assist Device Market, 2016-2022 ($ Billions)
- Figure 19 Global Cardiac Assist Device Market, 2016-2022 ($ Billions)
- Figure 20 Global Ventricular Assist Devices Market, 2016-2022 ($ Billions)
- Figure 21 Global Intra-Aortic Balloon Pump Market, 2016-2022 ($ Billions)
- Figure 22 Global Total Artificial Heart Market, 2016-2022 ($ Billions)
- Figure 23 Global Other Vascular Devices Market, 2016-2022 ($ Billions)
- Figure 24 Global Other Vascular Devices Market, by Type, 2016-2022 ($ Billions)
- Figure 25 Global Endovascular Grafts Market, 2016-2022 ($ Billions)
- Figure 26 Global IVC Filters Market, 2016-2022 ($ Billions)
- Figure 27 Global Occlusion Devices Market, 2016-2022 ($ Billions)
- Figure 28 North America Cardiovascular Devices Market, 2016-2022 ($ Billions)
- Figure 29 Estimated Cardiovascular Disease Deaths in the U.S., 2016 (%)
- Figure 30 Europe Cardiovascular Devices Market, 2016-2022 ($ Billions)
- Figure 31 Asia-Pacific Cardiovascular Devices Market, 2016-2022 ($ Billions)
- Figure 32 Middle East and Africa Cardiovascular Devices Market, 2016-2022 ($ Billions)
- Figure 33 Mortality from Non-Communicable Diseases in Africa, 2016 (%)
- Figure 34 South America Cardiovascular Devices Market, 2016-2022 ($ Billions)
- Figure 35 Global Adult Population with Cardiovascular Conditions, by Region, 2017 (%)
- Figure 36 Population aged 65 and above in G7 countries, 2016 (%)
- Figure 37 Bargaining Power of Suppliers
- Figure 38 Bargaining Power of Buyers
- Figure 39 Degree of Competition
- Figure 40 Threat of Substitution
- Figure 41 Threat of New Entrants
- Figure 42 Global Market Share of Major Players in CVD Industry, 2016 (%)
- Figure 43 BSC Regional Sales Share, 2016 (%)
- Figure 44 GE Healthcare Revenue Share, by Region, 2016 (%)
- Figure 45 GE Healthcare Revenue Share, by Operations, 2016 (%)
- Figure 46 J&J Cardiovascular Devices Sales, 2014-2016 ($ Billions)
- Figure 47 Medtronic Regional Sales Share, by Region, 2016 (%)
- Figure 48 Philips Healthcare Sales Share, by Operations, 2016 (%)
